Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China · Delayed Price · Currency is CNY 362.20
-21.80 (-5.68%)
At close: Sep 9, 2025
SHA:688506 Revenue
Sichuan Biokin Pharmaceutical had revenue of 85.60M CNY in the quarter ending June 30, 2025, a decrease of -5.52%. This brings the company's revenue in the last twelve months to 441.19M, down -92.40% year-over-year. In the year 2024, Sichuan Biokin Pharmaceutical had annual revenue of 5.82B with 936.31% growth.
Revenue (ttm)
441.19M
Revenue Growth
-92.40%
P/S Ratio
311.77
Revenue / Employee
156.23K
Employees
2,521
Market Cap
137.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.82B | 5.26B | 936.31% |
| Dec 31, 2023 | 561.87M | -141.41M | -20.11% |
| Dec 31, 2022 | 703.28M | -93.45M | -11.73% |
| Dec 31, 2021 | 796.73M | -215.98M | -21.33% |
| Dec 31, 2020 | 1.01B | -193.91M | -16.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Shanghai United Imaging Healthcare | 10.98B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |